{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:58:42Z","timestamp":1786978722710,"version":"build-2736575974"},"publisher-location":"Berlin, Heidelberg","reference-count":165,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642197024","type":"print"},{"value":"9783642197031","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/7854_2010_105","type":"book-chapter","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T05:33:00Z","timestamp":1294723980000},"page":"61-85","source":"Crossref","is-referenced-by-count":27,"title":["Transgenic Animal Models of Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Shang-Hsun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W. S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,12]]},"reference":[{"key":"105_CR1_105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00439-005-0025-9","volume":"118","author":"L Abuhatzira","year":"2005","unstructured":"Abuhatzira L, Makedonski K, Galil YP, Gak E, Ben Zeev B, Razin A, Shemer R (2005) Splicing mutation associated with Rett syndrome and an experimental approach for genetic diagnosis. Hum Genet 118:91\u201398","journal-title":"Hum Genet"},{"key":"105_CR2_105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/labinvest.3700480","volume":"87","author":"D Acehan","year":"2007","unstructured":"Acehan D, Xu Y, Stokes DL, Schlame M (2007) Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography. Lab Invest 87:40\u201348","journal-title":"Lab Invest"},{"key":"105_CR3_105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dnarep.2008.09.004","volume":"8","author":"K Acevedo-Torres","year":"2009","unstructured":"Acevedo-Torres K, Berrios L, Rosario N, Dufault V, Skatchkov S, Eaton MJ, Torres-Ramos CA, Ayala-Torres S (2009) Mitochondrial DNA damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington\u2019s disease. DNA Repair 8:126\u2013136","journal-title":"DNA Repair"},{"key":"105_CR4_105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"BI Bae","year":"2005","unstructured":"Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, Snyder SH, Sawa A (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron 47:29\u201341","journal-title":"Neuron"},{"key":"105_CR5_105","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0024-3205(79)90365-5","volume":"24","author":"K Beaumont","year":"1979","unstructured":"Beaumont K, Maurin Y, Reisine TD, Fields JZ, Spokes E, Bird ED, Yamamura HI (1979) Huntington\u2019s disease and its animal model: alterations in kainic acid binding. Life Sci 24:809\u2013816","journal-title":"Life Sci"},{"key":"105_CR6_105","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","volume":"448","author":"EJ Bennett","year":"2007","unstructured":"Bennett EJ, Shaler TA, Woodman B, Ryu KY, Zaitseva TS, Becker CH, Bates GP, Schulman H, Kopito RR (2007) Global changes to the ubiquitin system in Huntington\u2019s disease. Nature 448:704\u2013708","journal-title":"Nature"},{"key":"105_CR7_105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00002093-200207000-00005","volume":"16","author":"M Bergman","year":"2002","unstructured":"Bergman M, Salman H, Beloosesky Y, Djaldetti M, Bessler H (2002) Are peripheral blood cells from patients with Alzheimer disease more sensitive to apoptotic stimuli? Alzheimer Dis Assoc Disord 16:156\u2013160","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"105_CR8_105","doi-asserted-by":"crossref","first-page":"e5128","DOI":"10.1371\/journal.pone.0005128","volume":"4","author":"JS Bett","year":"2009","unstructured":"Bett JS, Cook C, Petrucelli L, Bates GP (2009) The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6\/2 transgenic mouse model of Huntington\u2019s disease. PLoS One 4:e5128","journal-title":"PLoS One"},{"key":"105_CR9_105","first-page":"534","volume":"52","author":"DH Black","year":"2002","unstructured":"Black DH, Saliki JT, Eberle R (2002) Development of a green fluorescent protein reporter cell line to reduce biohazards associated with detection of infectious Cercopithecine herpesvirus 1 (monkey B virus) in clinical specimens. Comp Med 52:534\u2013542","journal-title":"Comp Med"},{"key":"105_CR10_105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0304-3940(93)90752-7","volume":"149","author":"F Block","year":"1993","unstructured":"Block F, Kunkel M, Schwarz M (1993) Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats. Neurosci Lett 149:126\u2013128","journal-title":"Neurosci Lett"},{"key":"105_CR11_105","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","volume":"79","author":"MB Bogdanov","year":"2001","unstructured":"Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF (2001) Increased oxidative damage to DNA in a transgenic mouse model of Huntington\u2019s disease. J Neurochem 79:1246\u20131249","journal-title":"J Neurochem"},{"key":"105_CR12_105","first-page":"67","volume":"104","author":"RL Borison","year":"1979","unstructured":"Borison RL, Diamond BI (1979) Kainic acid animal model predicts therapeutic agents in Huntington\u2019s chorea. Trans Am Neurol Assoc 104:67\u201369","journal-title":"Trans Am Neurol Assoc"},{"key":"105_CR13_105","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","volume":"102","author":"F Borovecki","year":"2005","unstructured":"Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, Krainc D (2005) Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease. Proc Natl Acad Sci USA 102:11023\u201311028","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR14_105","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","volume":"63","author":"M Borrell-Pages","year":"2006","unstructured":"Borrell-Pages M, Zala D, Humbert S, Saudou F (2006) Huntington\u2019s disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63:2642\u20132660","journal-title":"Cell Mol Life Sci"},{"issue":"52","key":"105_CR15_105","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S (2009) Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci USA 106(52):22480\u201322485","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"105_CR16_105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/cr.2010.32","volume":"20","author":"JW Bradford","year":"2010","unstructured":"Bradford JW, Li S, Li XJ (2010a) Polyglutamine toxicity in non-neuronal cells. Cell Res 20(4):400\u2013407","journal-title":"Cell Res"},{"issue":"14","key":"105_CR17_105","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","volume":"285","author":"J Bradford","year":"2010","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S, Li XJ (2010b) Mutant huntingtin in glial cells exacerbates neurological symptoms of huntington disease mice. J Biol Chem 285(14):10653\u201310661","journal-title":"J Biol Chem"},{"key":"105_CR18_105","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","volume":"92","author":"E Brouillet","year":"1995","unstructured":"Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 92:7105\u20137109","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR19_105","doi-asserted-by":"crossref","first-page":"10458","DOI":"10.1073\/pnas.0401827101","volume":"101","author":"AW Bruce","year":"2004","unstructured":"Bruce AW, Donaldson IJ, Wood IC, Yerbury SA, Sadowski MI, Chapman M, Gottgens B, Buckley NJ (2004) Genome-wide analysis of repressor element 1 silencing transcription factor\/neuron-restrictive silencing factor (REST\/NRSF) target genes. Proc Natl Acad Sci USA 101:10458\u201310463","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR20_105","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10571-009-9367-5","volume":"29","author":"O Bugos","year":"2009","unstructured":"Bugos O, Bhide M, Zilka N (2009) Beyond the rat models of human neurodegenerative disorders. Cell Mol Neurobiol 29:859\u2013869","journal-title":"Cell Mol Neurobiol"},{"key":"105_CR21_105","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0306-4522(94)00431-4","volume":"64","author":"LH Burns","year":"1995","unstructured":"Burns LH, Pakzaban P, Deacon TW, Brownell AL, Tatter SB, Jenkins BG, Isacson O (1995) Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease. Neuroscience 64:1007\u20131017","journal-title":"Neuroscience"},{"key":"105_CR22_105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2164-8-126","volume":"8","author":"SL Butland","year":"2007","unstructured":"Butland SL, Devon RS, Huang Y, Mead CL, Meynert AM, Neal SJ, Lee SS, Wilkinson A, Yang GS, Yuen MM, Hayden MR, Holt RA, Leavitt BR, Ouellette BF (2007) CAG-encoded polyglutamine length polymorphism in the human genome. BMC Genomics 8:126","journal-title":"BMC Genomics"},{"key":"105_CR23_105","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J Neurosci 19:3248\u20133257","journal-title":"J Neurosci"},{"key":"105_CR24_105","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","volume":"95","author":"JH Cha","year":"1998","unstructured":"Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, Penney JB, Bates GP, Young AB (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci USA 95:6480\u20136485","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR25_105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7827-2-39","volume":"2","author":"AW Chan","year":"2004","unstructured":"Chan AW (2004) Transgenic nonhuman primates for neurodegenerative diseases. Reprod Biol Endocrinol 2:39","journal-title":"Reprod Biol Endocrinol"},{"key":"105_CR26_105","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/11.17.1939","volume":"11","author":"EY Chan","year":"2002","unstructured":"Chan EY, Luthi-Carter R, Strand A, Solano SM, Hanson SA, DeJohn MM, Kooperberg C, Chase KO, DiFiglia M, Young AB, Leavitt BR, Cha JH, Aronin N, Hayden MR, Olson JM (2002) Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington\u2019s disease. Hum Mol Genet 11:1939\u20131951","journal-title":"Hum Mol Genet"},{"key":"105_CR27_105","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1242\/dev.01652","volume":"132","author":"SC Chapman","year":"2005","unstructured":"Chapman SC, Lawson A, Macarthur WC, Wiese RJ, Loechel RH, Burgos-Trinidad M, Wakefield JK, Ramabhadran R, Mauch TJ, Schoenwolf GC (2005) Ubiquitous GFP expression in transgenic chickens using a lentiviral vector. Development 132:935\u2013940","journal-title":"Development"},{"key":"105_CR28_105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","volume":"22","author":"AS Chen-Plotkin","year":"2006","unstructured":"Chen-Plotkin AS, Sadri-Vakili G, Yohrling GJ, Braveman MW, Benn CL, Glajch KE, DiRocco DP, Farrell LA, Krainc D, Gines S, MacDonald ME, Cha JH (2006) Decreased association of the transcription factor Sp1 with genes downregulated in Huntington\u2019s disease. Neurobiol Dis 22:233\u2013241","journal-title":"Neurobiol Dis"},{"issue":"5","key":"105_CR29_105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddl481","volume":"16","author":"MC Chiang","year":"2007","unstructured":"Chiang MC, Chen HM, Lee YH, Chang HH, Wu YC, Soong BW, Chen CM, Wu YR, Liu CS, Niu DM, Wu JY, Chen YT, Chern Y (2007) Dysregulation of C\/EBPa by mutant Huntingtin causes the urea cycle deficiency in Huntington\u2019s disease. Hum Mol Genet 16(5):483\u2013498","journal-title":"Hum Mol Genet"},{"key":"105_CR30_105","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","volume":"18","author":"MC Chiang","year":"2009","unstructured":"Chiang MC, Chen HM, Lai HL, Chen HW, Chou SY, Chen CM, Tsai FJ, Chern Y (2009) The A2A adenosine receptor rescues the urea cycle deficiency of Huntington\u2019s disease by enhancing the activity of the ubiquitin-proteasome system. Hum Mol Genet 18:2929\u20132942","journal-title":"Hum Mol Genet"},{"key":"105_CR31_105","doi-asserted-by":"crossref","first-page":"16685","DOI":"10.1073\/pnas.0707842104","volume":"104","author":"V Chopra","year":"2007","unstructured":"Chopra V, Fox JH, Lieberman G, Dorsey K, Matson W, Waldmeier P, Housman DE, Kazantsev A, Young AB, Hersch S (2007) A small-molecule therapeutic lead for Huntington\u2019s disease: preclinical pharmacology and efficacy of C2-8 in the R6\/2 transgenic mouse. Proc Natl Acad Sci USA 104:16685\u201316689","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR32_105","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1073\/pnas.0511041103","volume":"103","author":"C Conaco","year":"2006","unstructured":"Conaco C, Otto S, Han JJ, Mandel G (2006) Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci USA 103:2422\u20132427","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR33_105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0070-2153(06)75002-5","volume":"75","author":"CM Cowan","year":"2006","unstructured":"Cowan CM, Raymond LA (2006) Selective neuronal degeneration in Huntington\u2019s disease. Curr Top Dev Biol 75:25\u201371","journal-title":"Curr Top Dev Biol"},{"key":"105_CR34_105","first-page":"251","volume":"14","author":"JT Coyle","year":"1979","unstructured":"Coyle JT (1979) An animal model for Huntington\u2019s disease. Biol Psychiatry 14:251\u2013276","journal-title":"Biol Psychiatry"},{"key":"105_CR35_105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.02.102","volume":"1088","author":"SF Crocker","year":"2006","unstructured":"Crocker SF, Costain WJ, Robertson HA (2006) DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington\u2019s mice (R6\/2) reveals neuroinflammation and insulin associations. Brain Res 1088:176\u2013186","journal-title":"Brain Res"},{"key":"105_CR36_105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548","journal-title":"Cell"},{"key":"105_CR37_105","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.6039-08.2009","volume":"29","author":"H Diekmann","year":"2009","unstructured":"Diekmann H, Anichtchik O, Fleming A, Futter M, Goldsmith P, Roach A, Rubinsztein DC (2009) Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish. J Neurosci 29:1343\u20131349","journal-title":"J Neurosci"},{"key":"105_CR38_105","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","volume":"14","author":"M DiFiglia","year":"1995","unstructured":"DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel JP, Carraway R, Reeves SA et al (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14:1075\u20131081","journal-title":"Neuron"},{"key":"105_CR39_105","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"105_CR40_105","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","volume":"27","author":"JP Dompierre","year":"2007","unstructured":"Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, Humbert S, Saudou F (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington\u2019s disease by increasing tubulin acetylation. J Neurosci 27:3571\u20133583","journal-title":"J Neurosci"},{"issue":"6","key":"105_CR41_105","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1095\/biolreprod.109.077529","volume":"81","author":"ZR Donaldson","year":"2009","unstructured":"Donaldson ZR, Yang SH, Chan AW, Young LJ (2009) Production of germline transgenic prairie voles (Microtus ochrogaster) using lentiviral vectors. Biol Reprod 81(6):1189\u20131195","journal-title":"Biol Reprod"},{"key":"105_CR42_105","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1242\/dev.125.8.1529","volume":"125","author":"I Dragatsis","year":"1998","unstructured":"Dragatsis I, Efstratiadis A, Zeitlin S (1998) Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues. Development 125:1529\u20131539","journal-title":"Development"},{"key":"105_CR43_105","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, Mouradian MM, Young AB, Tanese N, Krainc D (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\u2019s disease. Science 296:2238\u20132243","journal-title":"Science"},{"key":"105_CR44_105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","volume":"39","author":"AM Estrada Sanchez","year":"2008","unstructured":"Estrada Sanchez AM, Mejia-Toiber J, Massieu L (2008) Excitotoxic neuronal death and the pathogenesis of Huntington\u2019s disease. Arch Med Res 39:265\u2013276","journal-title":"Arch Med Res"},{"key":"105_CR45_105","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","volume":"27","author":"HB Fernandes","year":"2007","unstructured":"Fernandes HB, Baimbridge KG, Church J, Hayden MR, Raymond LA (2007) Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington\u2019s disease. J Neurosci 27:13614\u201313623","journal-title":"J Neurosci"},{"key":"105_CR46_105","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","volume":"24","author":"RJ Ferrante","year":"2004","unstructured":"Ferrante RJ, Ryu H, Kubilus JK, D'Mello S, Sugars KL, Lee J, Lu P, Smith K, Browne S, Beal MF, Kristal BS, Stavrovskaya IG, Hewett S, Rubinsztein DC, Langley B, Ratan RR (2004) Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington\u2019s disease. J Neurosci 24:10335\u201310342","journal-title":"J Neurosci"},{"key":"105_CR47_105","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"J Gafni","year":"2002","unstructured":"Gafni J, Ellerby LM (2002) Calpain activation in Huntington\u2019s disease. J Neurosci 22:4842\u20134849","journal-title":"J Neurosci"},{"key":"105_CR48_105","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","volume":"280","author":"G Gardian","year":"2005","unstructured":"Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, Ryu H, Langley B, Ratan RR, Ferrante RJ, Beal MF (2005) Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington\u2019s disease. J Biol Chem 280:556\u2013563","journal-title":"J Biol Chem"},{"key":"105_CR49_105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138","journal-title":"Cell"},{"key":"105_CR50_105","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.M709555200","volume":"283","author":"FN Gellerich","year":"2008","unstructured":"Gellerich FN, Gizatullina Z, Nguyen HP, Trumbeckaite S, Vielhaber S, Seppet E, Zierz S, Landwehrmeyer B, Riess O, von Horsten S, Striggow F (2008) Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats. J Biol Chem 283:30715\u201330724","journal-title":"J Biol Chem"},{"key":"105_CR51_105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature02426","volume":"428","author":"RA Gibbs","year":"2004","unstructured":"Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis L, DeRamo C, Delgado O, Dugan-Rocha S, Miner G, Morgan M, Hawes A, Gill R, Celera HRA, Adams MD, Amanatides PG, Baden-Tillson H, Barnstead M, Chin S, Evans CA, Ferriera S, Fosler C, Glodek A, Gu Z, Jennings D, Kraft CL, Nguyen T, Pfannkoch CM, Sitter C, Sutton GG, Venter JC, Woodage T, Smith D, Lee HM, Gustafson E, Cahill P, Kana A, Doucette-Stamm L, Weinstock K, Fechtel K, Weiss RB, Dunn DM, Green ED, Blakesley RW, Bouffard GG, De Jong PJ, Osoegawa K, Zhu B, Marra M, Schein J, Bosdet I, Fjell C, Jones S, Krzywinski M, Mathewson C, Siddiqui A, Wye N, McPherson J, Zhao S, Fraser CM, Shetty J, Shatsman S, Geer K, Chen Y, Abramzon S, Nierman WC, Havlak PH, Chen R, Durbin KJ, Egan A, Ren Y, Song XZ, Li B, Liu Y, Qin X, Cawley S, Cooney AJ, D'Souza LM, Martin K, Wu JQ, Gonzalez-Garay ML, Jackson AR, Kalafus KJ, McLeod MP, Milosavljevic A, Virk D, Volkov A, Wheeler DA, Zhang Z, Bailey JA, Eichler EE, Tuzun E et al (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428:493\u2013521","journal-title":"Nature"},{"key":"105_CR52_105","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","volume":"283","author":"F Giorgini","year":"2008","unstructured":"Giorgini F, Moller T, Kwan W, Zwilling D, Wacker JL, Hong S, Tsai LC, Cheah CS, Schwarcz R, Guidetti P, Muchowski PJ (2008) Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment. J Biol Chem 283:7390\u20137400","journal-title":"J Biol Chem"},{"key":"105_CR53_105","doi-asserted-by":"crossref","unstructured":"Gondo Y, Murata T, Makino S, Fukumura R, Ishitsuka Y (2011) Mouse mutagenesis and disease models for Neuropsychiatric disorders. In: Current topics in behavioural neurosciences. Springer, Heidelberg. doi: 10.1007\/7854_2010_106","DOI":"10.1007\/7854_2010_106"},{"key":"105_CR54_105","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z, Warby SC, Doty CN, Roy S, Wellington CL, Leavitt BR, Raymond LA, Nicholson DW, Hayden MR (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant Huntington. Cell 125:1179\u20131191","journal-title":"Cell"},{"key":"105_CR55_105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","volume":"40","author":"S Gunawardena","year":"2003","unstructured":"Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, Gordesky-Gold B, Sintasath L, Bonini NM, Goldstein LS (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40:25\u201340","journal-title":"Neuron"},{"key":"105_CR56_105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY et al (1983) A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature 306:234\u2013238","journal-title":"Nature"},{"key":"105_CR57_105","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology. J Neurosci 19:2522\u20132534","journal-title":"J Neurosci"},{"key":"105_CR58_105","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1093\/nar\/gkh976","volume":"32","author":"VI Hashem","year":"2004","unstructured":"Hashem VI, Pytlos MJ, Klysik EA, Tsuji K, Khajavi M, Ashizawa T, Sinden RR (2004) Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients. Nucleic Acids Res 32:6334\u20136346","journal-title":"Nucleic Acids Res"},{"key":"105_CR59_105","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","volume":"27","author":"MY Heng","year":"2007","unstructured":"Heng MY, Tallaksen-Greene SJ, Detloff PJ, Albin RL (2007) Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington\u2019s disease. J Neurosci 27:8989\u20138998","journal-title":"J Neurosci"},{"key":"105_CR60_105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"105_CR61_105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1095\/biolreprod.104.028472","volume":"71","author":"A Hofmann","year":"2004","unstructured":"Hofmann A, Zakhartchenko V, Weppert M, Sebald H, Wenigerkind H, Brem G, Wolf E, Pfeifer A (2004) Generation of transgenic cattle by lentiviral gene transfer into oocytes. Biol Reprod 71:405\u2013409","journal-title":"Biol Reprod"},{"key":"105_CR62_105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","volume":"24","author":"CC Huang","year":"1998","unstructured":"Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel JP, MacDonald ME, Gusella JF (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet 24:217\u2013233","journal-title":"Somat Cell Mol Genet"},{"key":"105_CR63_105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0079-6123(08)62643-6","volume":"82","author":"O Isacson","year":"1990","unstructured":"Isacson O, Hantraye P, Maziere M, Sofroniew MV, Riche D (1990) Apomorphine-induced dyskinesias after excitotoxic caudate-putamen lesions and the effects of neural transplantation in non-human primates. Prog Brain Res 82:523\u2013533","journal-title":"Prog Brain Res"},{"key":"105_CR64_105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nn1174","volume":"7","author":"P Jin","year":"2004","unstructured":"Jin P, Zarnescu DC, Ceman S, Nakamoto M, Mowrey J, Jongens TA, Nelson DL, Moses K, Warren ST (2004) Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci 7:113\u2013117","journal-title":"Nat Neurosci"},{"key":"105_CR65_105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","volume":"97","author":"MA Johnson","year":"2006","unstructured":"Johnson MA, Rajan V, Miller CE, Wightman RM (2006) Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease. J Neurochem 97:737\u2013746","journal-title":"J Neurochem"},{"key":"105_CR66_105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"R Johnson","year":"2008","unstructured":"Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ (2008) A microRNA-based gene dysregulation pathway in Huntington\u2019s disease. Neurobiol Dis 29:438\u2013445","journal-title":"Neurobiol Dis"},{"key":"105_CR67_105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ng0597-44","volume":"16","author":"MA Kalchman","year":"1997","unstructured":"Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, Kazemi-Esfarjani P, Lynn FC, Wellington C, Metzler M, Goldberg YP, Kanazawa I, Gietz RD, Hayden MR (1997) HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat Genet 16:44\u201353","journal-title":"Nat Genet"},{"key":"105_CR68_105","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.221451398","volume":"98","author":"YJ Kim","year":"2001","unstructured":"Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, Qin ZH, Aronin N, DiFiglia M (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington\u2019s disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci USA 98:12784\u201312789","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR69_105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.nbd.2005.11.012","volume":"22","author":"YJ Kim","year":"2006","unstructured":"Kim YJ, Sapp E, Cuiffo BG, Sobin L, Yoder J, Kegel KB, Qin ZH, Detloff P, Aronin N, DiFiglia M (2006) Lysosomal proteases are involved in generation of N-terminal huntingtin fragments. Neurobiol Dis 22:346\u2013356","journal-title":"Neurobiol Dis"},{"key":"105_CR70_105","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317:1220\u20131224","journal-title":"Science"},{"key":"105_CR71_105","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.neuroscience.2007.03.036","volume":"146","author":"VW Kung","year":"2007","unstructured":"Kung VW, Hassam R, Morton AJ, Jones S (2007) Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6\/2 mouse model of Huntington\u2019s disease. Neuroscience 146:1571\u20131580","journal-title":"Neuroscience"},{"key":"105_CR72_105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pneurobio.2004.02.002","volume":"72","author":"WT Lee","year":"2004","unstructured":"Lee WT, Chang C (2004) Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington\u2019s disease. Prog Neurobiol 72:87\u2013110","journal-title":"Prog Neurobiol"},{"key":"105_CR73_105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","volume":"27","author":"MS Levine","year":"2004","unstructured":"Levine MS, Cepeda C, Hickey MA, Fleming SM, Chesselet MF (2004) Genetic mouse models of Huntington\u2019s and Parkinson\u2019s diseases: illuminating but imperfect. Trends Neurosci 27:691\u2013697","journal-title":"Trends Neurosci"},{"key":"105_CR74_105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"SH Li","year":"2004","unstructured":"Li SH, Li XJ (2004) Huntingtin-protein interactions and the pathogenesis of Huntington\u2019s disease. Trends Genet 20:146\u2013154","journal-title":"Trends Genet"},{"key":"105_CR75_105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-1-19","volume":"1","author":"S Li","year":"2006","unstructured":"Li S, Li XJ (2006) Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener 1:19","journal-title":"Mol Neurodegener"},{"key":"105_CR76_105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/378398a0","volume":"378","author":"XJ Li","year":"1995","unstructured":"Li XJ, Li SH, Sharp AH, Nucifora FC Jr, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378:398\u2013402","journal-title":"Nature"},{"key":"105_CR77_105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","volume":"9","author":"JY Li","year":"2003","unstructured":"Li JY, Plomann M, Brundin P (2003) Huntington\u2019s disease: a synaptopathy? Trends Mol Med 9:414\u2013420","journal-title":"Trends Mol Med"},{"issue":"11","key":"105_CR78_105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbagrm.2008.07.003","volume":"1779","author":"Y Li","year":"2008","unstructured":"Li Y, Lin L, Jin P (2008) The microRNA pathway and fragile X mental retardation protein. Biochim Biophys Acta 1779(11):702\u2013705","journal-title":"Biochim Biophys Acta"},{"key":"105_CR79_105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature03315","volume":"433","author":"LP Lim","year":"2005","unstructured":"Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769\u2013773","journal-title":"Nature"},{"key":"105_CR80_105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10:137\u2013144","journal-title":"Hum Mol Genet"},{"key":"105_CR81_105","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","volume":"19","author":"LA Lione","year":"1999","unstructured":"Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB (1999) Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation. J Neurosci 19:10428\u201310437","journal-title":"J Neurosci"},{"key":"105_CR82_105","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.1067081","volume":"295","author":"C Lois","year":"2002","unstructured":"Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868\u2013872","journal-title":"Science"},{"key":"105_CR83_105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/WNR.0b013e3280148e8b","volume":"18","author":"WJ Lukiw","year":"2007","unstructured":"Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer\u2019s disease hippocampus. Neuroreport 18:297\u2013300","journal-title":"Neuroreport"},{"key":"105_CR84_105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","volume":"10","author":"A Lunkes","year":"2002","unstructured":"Lunkes A, Lindenberg KS, Ben-Haiem L, Weber C, Devys D, Landwehrmeyer GB, Mandel JL, Trottier Y (2002) Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell 10:259\u2013269","journal-title":"Mol Cell"},{"key":"105_CR85_105","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","volume":"11","author":"R Luthi-Carter","year":"2002","unstructured":"Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, Woods AM, Chan EY, Kooperberg C, Krainc D, Young AB, Tapscott SJ, Olson JM (2002) Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 11:1911\u20131926","journal-title":"Hum Mol Genet"},{"key":"105_CR86_105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1750-3639.2006.00040.x","volume":"17","author":"M Maat-Schieman","year":"2007","unstructured":"Maat-Schieman M, Roos R, Losekoot M, Dorsman J, Welling-Graafland C, Hegeman-Kleinn I, Broeyer F, Breuning M, van Duinen S (2007) Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington\u2019s disease. Brain Pathol 17:31\u201337","journal-title":"Brain Pathol"},{"key":"105_CR87_105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"105_CR88_105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","volume":"31","author":"T Mantamadiotis","year":"2002","unstructured":"Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin Villalba A, Tronche F, Kellendonk C, Gau D, Kapfhammer J, Otto C, Schmid W, Schutz G (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 31:47\u201354","journal-title":"Nat Genet"},{"issue":"Sp No 2","key":"105_CR89_105","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1093\/hmg\/ddg271","volume":"12","author":"JL Marsh","year":"2003","unstructured":"Marsh JL, Pallos J, Thompson LM (2003) Fly models of Huntington\u2019s disease. Hum Mol Genet 12(Sp No 2):R187\u2013R193","journal-title":"Hum Mol Genet"},{"key":"105_CR90_105","doi-asserted-by":"crossref","first-page":"13986","DOI":"10.1073\/pnas.0906463106","volume":"106","author":"CJ Maynard","year":"2009","unstructured":"Maynard CJ, Bottcher C, Ortega Z, Smith R, Florea BI, Diaz-Hernandez M, Brundin P, Overkleeft HS, Li JY, Lucas JJ, Dantuma NP (2009) Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin\/proteasome system impairment. Proc Natl Acad Sci USA 106:13986\u201313991","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR91_105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-4886(03)00044-X","volume":"181","author":"JL McBride","year":"2003","unstructured":"McBride JL, During MJ, Wuu J, Chen EY, Leurgans SE, Kordower JH (2003) Structural and functional neuroprotection in a rat model of Huntington\u2019s disease by viral gene transfer of GDNF. Exp Neurol 181:213\u2013223","journal-title":"Exp Neurol"},{"key":"105_CR92_105","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1073\/pnas.261400698","volume":"98","author":"A McCampbell","year":"2001","unstructured":"McCampbell A, Taye AA, Whitty L, Penney E, Steffan JS, Fischbeck KH (2001) Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci USA 98:15179\u201315184","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR93_105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s002210000465","volume":"134","author":"A Meldrum","year":"2000","unstructured":"Meldrum A, Page KJ, Everitt BJ, Dunnett SB (2000) Age-dependence of malonate-induced striatal toxicity. Exp Brain Res 134:335\u2013343","journal-title":"Exp Brain Res"},{"key":"105_CR94_105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0197-4580(01)00257-3","volume":"23","author":"M Morocz","year":"2002","unstructured":"Morocz M, Kalman J, Juhasz A, Sinko I, McGlynn AP, Downes CS, Janka Z, Rasko I (2002) Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer\u2019s disease. Neurobiol Aging 23:47\u201353","journal-title":"Neurobiol Aging"},{"key":"105_CR95_105","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, Dawson TM, Ross CA (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291:2423\u20132428","journal-title":"Science"},{"key":"105_CR96_105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrg2100","volume":"8","author":"L Ooi","year":"2007","unstructured":"Ooi L, Wood IC (2007) Chromatin crosstalk in development and disease: lessons from REST. Nat Rev Genet 8:544\u2013554","journal-title":"Nat Rev Genet"},{"key":"105_CR97_105","doi-asserted-by":"crossref","first-page":"16027","DOI":"10.1074\/jbc.M710606200","volume":"283","author":"AL Orr","year":"2008","unstructured":"Orr AL, Huang S, Roberts MA, Reed JC, Li S, Li XJ (2008) Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice. J Biol Chem 283:16027\u201316036","journal-title":"J Biol Chem"},{"key":"105_CR98_105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1083\/jcb.200509091","volume":"172","author":"A Pal","year":"2006","unstructured":"Pal A, Severin F, Lommer B, Shevchenko A, Zerial M (2006) Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington\u2019s disease. J Cell Biol 172:605\u2013618","journal-title":"J Cell Biol"},{"key":"105_CR99_105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0076-6879(07)38017-8","volume":"438","author":"A Pal","year":"2008","unstructured":"Pal A, Severin F, Hopfner S, Zerial M (2008) Regulation of endosome dynamics by Rab5 and Huntingtin-HAP40 effector complex in physiological versus pathological conditions. Methods Enzymol 438:239\u2013257","journal-title":"Methods Enzymol"},{"key":"105_CR100_105","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1523\/JNEUROSCI.16-09-03019.1996","volume":"16","author":"S Palfi","year":"1996","unstructured":"Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, Guyot MC, Peschanski M, Hantraye P (1996) Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington\u2019s disease. J Neurosci 16:3019\u20133025","journal-title":"J Neurosci"},{"key":"105_CR101_105","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","volume":"15","author":"S Palfi","year":"2007","unstructured":"Palfi S, Brouillet E, Jarraya B, Bloch J, Jan C, Shin M, Conde F, Li XJ, Aebischer P, Hantraye P, Deglon N (2007) Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates. Mol Ther 15:1444\u20131451","journal-title":"Mol Ther"},{"key":"105_CR102_105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736","journal-title":"Nat Neurosci"},{"key":"105_CR103_105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1152\/physiolgenomics.00069.2007","volume":"31","author":"F Park","year":"2007","unstructured":"Park F (2007) Lentiviral vectors: are they the future of animal transgenesis? Physiol Genomics 31:159\u2013173","journal-title":"Physiol Genomics"},{"key":"105_CR104_105","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1083\/jcb.143.6.1457","volume":"143","author":"MK Perez","year":"1998","unstructured":"Perez MK, Paulson HL, Pendse SJ, Saionz SJ, Bonini NM, Pittman RN (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol 143:1457\u20131470","journal-title":"J Cell Biol"},{"key":"105_CR105_105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/00005072-199608000-00001","volume":"55","author":"A Peters","year":"1996","unstructured":"Peters A, Rosene DL, Moss MB, Kemper TL, Abraham CR, Tigges J, Albert MS (1996) Neurobiological bases of age-related cognitive decline in the rhesus monkey. J Neuropathol Exp Neurol 55:861\u2013874","journal-title":"J Neuropathol Exp Neurol"},{"key":"105_CR106_105","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","volume":"18","author":"J Phan","year":"2009","unstructured":"Phan J, Hickey MA, Zhang P, Chesselet MF, Reue K (2009) Adipose tissue dysfunction tracks disease progression in two Huntington\u2019s disease mouse models. Hum Mol Genet 18:1006\u20131016","journal-title":"Hum Mol Genet"},{"key":"105_CR107_105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0197-4580(87)90038-8","volume":"8","author":"SK Presty","year":"1987","unstructured":"Presty SK, Bachevalier J, Walker LC, Struble RG, Price DL, Mishkin M, Cork LC (1987) Age differences in recognition memory of the rhesus monkey (Macaca mulatta). Neurobiol Aging 8:435\u2013440","journal-title":"Neurobiol Aging"},{"key":"105_CR108_105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1100\/tsw.2007.208","volume":"7","author":"A Qurashi","year":"2007","unstructured":"Qurashi A, Chang S, Peng J (2007) Role of microRNA pathway in mental retardation. ScientificWorldJournal 7:146\u2013154","journal-title":"ScientificWorldJournal"},{"key":"105_CR109_105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2008.12.005","volume":"34","author":"S Ramaswamy","year":"2009","unstructured":"Ramaswamy S, McBride JL, Han I, Berry-Kravis EM, Zhou L, Herzog CD, Gasmi M, Bartus RT, Kordower JH (2009) Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington\u2019s disease. Neurobiol Dis 34:40\u201350","journal-title":"Neurobiol Dis"},{"key":"105_CR110_105","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1242\/jcs.025726","volume":"121","author":"B Ravikumar","year":"2008","unstructured":"Ravikumar B, Imarisio S, Sarkar S, O'Kane CJ, Rubinsztein DC (2008) Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J Cell Sci 121:1649\u20131660","journal-title":"J Cell Sci"},{"key":"105_CR111_105","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1523\/JNEUROSCI.1251-06.2006","volume":"26","author":"J Rong","year":"2006","unstructured":"Rong J, McGuire JR, Fang ZH, Sheng G, Shin JY, Li SH, Li XJ (2006) Regulation of intracellular trafficking of huntingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth. J Neurosci 26:6019\u20136030","journal-title":"J Neurosci"},{"key":"105_CR112_105","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1002\/jnr.21326","volume":"85","author":"J Rong","year":"2007","unstructured":"Rong J, Li SH, Li XJ (2007) Regulation of intracellular HAP1 trafficking. J Neurosci Res 85:3025\u20133029","journal-title":"J Neurosci Res"},{"key":"105_CR113_105","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","volume":"65","author":"HD Rosas","year":"2005","unstructured":"Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B (2005) Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65:745\u2013747","journal-title":"Neurology"},{"key":"105_CR114_105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2006.09.056","volume":"410","author":"S Rossi","year":"2006","unstructured":"Rossi S, Prosperetti C, Picconi B, De Chiara V, Mataluni G, Bernardi G, Calabresi P, Centonze D (2006) Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington\u2019s disease. Neurosci Lett 410:6\u201310","journal-title":"Neurosci Lett"},{"key":"105_CR115_105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.expneurol.2004.01.006","volume":"187","author":"JK Ryu","year":"2004","unstructured":"Ryu JK, Kim SU, McLarnon JG (2004) Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington\u2019s disease. Exp Neurol 187:150\u2013159","journal-title":"Exp Neurol"},{"key":"105_CR116_105","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ (2006) ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease. Proc Natl Acad Sci USA 103:19176\u201319181","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR117_105","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","volume":"16","author":"G Sadri-Vakili","year":"2007","unstructured":"Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P, Overland RP, Glajch KE, Xia E, Qiu Z, Hersch SM, Clark TW, Yohrling GJ, Cha JH (2007) Histones associated with downregulated genes are hypo-acetylated in Huntington\u2019s disease models. Hum Mol Genet 16:1293\u20131306","journal-title":"Hum Mol Genet"},{"key":"105_CR118_105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature08090","volume":"459","author":"E Sasaki","year":"2009","unstructured":"Sasaki E, Suemizu H, Shimada A, Hanazawa K, Oiwa R, Kamioka M, Tomioka I, Sotomaru Y, Hirakawa R, Eto T, Shiozawa S, Maeda T, Ito M, Ito R, Kito C, Yagihashi C, Kawai K, Miyoshi H, Tanioka Y, Tamaoki N, Habu S, Okano H, Nomura T (2009) Generation of transgenic non-human primates with germline transmission. Nature 459:523\u2013527","journal-title":"Nature"},{"key":"105_CR119_105","doi-asserted-by":"crossref","first-page":"10820","DOI":"10.1073\/pnas.0800658105","volume":"105","author":"JN Savas","year":"2008","unstructured":"Savas JN, Makusky A, Ottosen S, Baillat D, Then F, Krainc D, Shiekhattar R, Markey SP, Tanese N (2008) Huntington\u2019s disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proc Natl Acad Sci USA 105:10820\u201310825","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR120_105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nbd.2008.09.016","volume":"33","author":"SJ Sawiak","year":"2009","unstructured":"Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA (2009) Voxel-based morphometry in the R6\/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiol Dis 33:20\u201327","journal-title":"Neurobiol Dis"},{"key":"105_CR121_105","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20070823","volume":"204","author":"A Schaefer","year":"2007","unstructured":"Schaefer A, O'Carroll D, Tan CL, Hillman D, Sugimori M, Llinas R, Greengard P (2007) Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 204:1553\u20131558","journal-title":"J Exp Med"},{"key":"105_CR122_105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8:397\u2013407","journal-title":"Hum Mol Genet"},{"key":"105_CR123_105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/nen.0b013e318040b2c8","volume":"66","author":"G Schilling","year":"2007","unstructured":"Schilling G, Klevytska A, Tebbenkamp AT, Juenemann K, Cooper J, Gonzales V, Slunt H, Poirer M, Ross CA, Borchelt DR (2007) Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models. J Neuropathol Exp Neurol 66:313\u2013320","journal-title":"J Neuropathol Exp Neurol"},{"key":"105_CR124_105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ana.410020407","volume":"2","author":"R Schwarcz","year":"1977","unstructured":"Schwarcz R, Bennett JP Jr, Coyle JT (1977) Inhibitors of GABA metabolism: implications for Huntington\u2019s disease. Ann Neurol 2:299\u2013303","journal-title":"Ann Neurol"},{"key":"105_CR125_105","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","volume":"14","author":"AH Sharp","year":"1995","unstructured":"Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A et al (1995) Widespread expression of Huntington\u2019s disease gene (IT15) protein product. Neuron 14:1065\u20131074","journal-title":"Neuron"},{"key":"105_CR126_105","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/archneur.63.11.1529","volume":"63","author":"FR Sharp","year":"2006","unstructured":"Sharp FR, Xu H, Lit L, Walker W, Apperson M, Gilbert DL, Glauser TA, Wong B, Hershey A, Liu DZ, Pinter J, Zhan X, Liu X, Ran R (2006) The future of genomic profiling of neurological diseases using blood. Arch Neurol 63:1529\u20131536","journal-title":"Arch Neurol"},{"key":"105_CR127_105","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.08.001","volume":"21","author":"J Shehadeh","year":"2006","unstructured":"Shehadeh J, Fernandes HB, Zeron Mullins MM, Graham RK, Leavitt BR, Hayden MR, Raymond LA (2006) Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease. Neurobiol Dis 21:392\u2013403","journal-title":"Neurobiol Dis"},{"key":"105_CR128_105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/79139","volume":"26","author":"T Shimohata","year":"2000","unstructured":"Shimohata T, Nakajima T, Yamada M, Uchida C, Onodera O, Naruse S, Kimura T, Koide R, Nozaki K, Sano Y, Ishiguro H, Sakoe K, Ooshima T, Sato A, Ikeuchi T, Oyake M, Sato T, Aoyagi Y, Hozumi I, Nagatsu T, Takiyama Y, Nishizawa M, Goto J, Kanazawa I, Davidson I, Tanese N, Takahashi H, Tsuji S (2000) Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet 26:29\u201336","journal-title":"Nat Genet"},{"issue":"6","key":"105_CR129_105","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171(6):1001\u20131012","journal-title":"J Cell Biol"},{"key":"105_CR130_105","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"105_CR131_105","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1073\/pnas.0400285101","volume":"101","author":"SA Small","year":"2004","unstructured":"Small SA, Chawla MK, Buonocore M, Rapp PR, Barnes CA (2004) Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc Natl Acad Sci USA 101:7181\u20137186","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR132_105","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA 97:6763\u20136768","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR133_105","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, Kurokawa R, Housman DE, Jackson GR, Marsh JL, Thompson LM (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739\u2013743","journal-title":"Nature"},{"key":"105_CR134_105","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","volume":"14","author":"AD Strand","year":"2005","unstructured":"Strand AD, Aragaki AK, Shaw D, Bird T, Holton J, Turner C, Tapscott SJ, Tabrizi SJ, Schapira AH, Kooperberg C, Olson JM (2005) Gene expression in Huntington\u2019s disease skeletal muscle: a potential biomarker. Hum Mol Genet 14:1863\u20131876","journal-title":"Hum Mol Genet"},{"key":"105_CR135_105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/hmg\/ddl467","volume":"16","author":"AN Strehlow","year":"2007","unstructured":"Strehlow AN, Li JZ, Myers RM (2007) Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space. Hum Mol Genet 16:391\u2013409","journal-title":"Hum Mol Genet"},{"key":"105_CR136_105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19:233\u2013238","journal-title":"Trends Genet"},{"key":"105_CR137_105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(03)00569-5","volume":"40","author":"G Szebenyi","year":"2003","unstructured":"Szebenyi G, Morfini GA, Babcock A, Gould M, Selkoe K, Stenoien DL, Young M, Faber PW, MacDonald ME, McPhaul MJ, Brady ST (2003) Neuropathogenic forms of Huntington and androgen receptor inhibit fast axonal transport. Neuron 40:41\u201352","journal-title":"Neuron"},{"key":"105_CR138_105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.ejhg.5201562","volume":"14","author":"A Tabchy","year":"2006","unstructured":"Tabchy A, Housman D (2006) Huntington\u2019s disease: a transcriptional report card from the peripheral blood: can it measure disease progression in Huntington\u2019s disease? Eur J Hum Genet 14:649\u2013650","journal-title":"Eur J Hum Genet"},{"key":"105_CR139_105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neulet.2006.07.036","volume":"406","author":"Y Temel","year":"2006","unstructured":"Temel Y, Cao C, Vlamings R, Blokland A, Ozen H, Steinbusch HW, Michelsen KA, von Horsten S, Schmitz C, Visser-Vandewalle V (2006) Motor and cognitive improvement by deep brain stimulation in a transgenic rat model of Huntington\u2019s disease. Neurosci Lett 406:138\u2013141","journal-title":"Neurosci Lett"},{"key":"105_CR140_105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"105_CR141_105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1471-4159.2002.00940.x","volume":"82","author":"T Toneff","year":"2002","unstructured":"Toneff T, Mende-Mueller L, Wu Y, Hwang SR, Bundey R, Thompson LM, Chesselet MF, Hook V (2002) Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain. J Neurochem 82:84\u201392","journal-title":"J Neurochem"},{"key":"105_CR142_105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0595-104","volume":"10","author":"Y Trottier","year":"1995","unstructured":"Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agid Y, Hirsch EC, Mandel JL (1995) Cellular localization of the Huntington\u2019s disease protein and discrimination of the normal and mutated form. Nat Genet 10:104\u2013110","journal-title":"Nat Genet"},{"key":"105_CR143_105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","volume":"5","author":"TM Tsang","year":"2006","unstructured":"Tsang TM, Woodman B, McLoughlin GA, Griffin JL, Tabrizi SJ, Bates GP, Holmes E (2006) Metabolic characterization of the R6\/2 transgenic mouse model of Huntington\u2019s disease by high-resolution MAS 1H NMR spectroscopy. J Proteome Res 5:483\u2013492","journal-title":"J Proteome Res"},{"key":"105_CR144_105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00702-009-0253-6","volume":"116","author":"E Vamos","year":"2009","unstructured":"Vamos E, Voros K, Zadori D, Vecsei L, Klivenyi P (2009) Neuroprotective effects of probenecid in a transgenic animal model of Huntington\u2019s disease. J Neural Transm 116:1079\u20131086","journal-title":"J Neural Transm"},{"key":"105_CR145_105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","volume":"29","author":"JM Burg van der","year":"2008","unstructured":"van der Burg JM, Bacos K, Wood NI, Lindqvist A, Wierup N, Woodman B, Wamsteeker JI, Smith R, Deierborg T, Kuhar MJ, Bates GP, Mulder H, Erlanson-Albertsson C, Morton AJ, Brundin P, Petersen A, Bjorkqvist M (2008) Increased metabolism in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 29:41\u201351","journal-title":"Neurobiol Dis"},{"key":"105_CR146_105","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, Hayden MR (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease. J Neurosci 25:4169\u20134180","journal-title":"J Neurosci"},{"key":"105_CR147_105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","volume":"26","author":"JM Raamsdonk Van","year":"2007","unstructured":"Van Raamsdonk JM, Metzler M, Slow E, Pearson J, Schwab C, Carroll J, Graham RK, Leavitt BR, Hayden MR (2007a) Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain. Neurobiol Dis 26:189\u2013200","journal-title":"Neurobiol Dis"},{"key":"105_CR148_105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainresbull.2006.10.018","volume":"72","author":"JM Raamsdonk Van","year":"2007","unstructured":"Van Raamsdonk JM, Warby SC, Hayden MR (2007b) Selective degeneration in YAC mouse models of Huntington disease. Brain Res Bull 72:124\u2013131","journal-title":"Brain Res Bull"},{"key":"105_CR149_105","doi-asserted-by":"crossref","first-page":"16426","DOI":"10.1073\/pnas.0508448102","volume":"102","author":"N Vo","year":"2005","unstructured":"Vo N, Klein ME, Varlamova O, Keller DM, Yamamoto T, Goodman RH, Impey S (2005) A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci USA 102:16426\u201316431","journal-title":"Proc Natl Acad Sci USA"},{"key":"105_CR150_105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","volume":"12","author":"S Horsten von","year":"2003","unstructured":"von Horsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-Hartlieb S, Schulz JB, Grasshoff U, Bauer I, Vieira-Saecker AM, Paul M, Jones L, Lindenberg KS, Landwehrmeyer B, Bauer A, Li XJ, Riess O (2003) Transgenic rat model of Huntington\u2019s disease. Hum Mol Genet 12:617\u2013624","journal-title":"Hum Mol Genet"},{"key":"105_CR151_105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"105_CR152_105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"105_CR153_105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"105_CR154_105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0197-4580(88)80130-1","volume":"9","author":"LC Walker","year":"1988","unstructured":"Walker LC, Kitt CA, Struble RG, Wagster MV, Price DL, Cork LC (1988) The neural basis of memory decline in aged monkeys. Neurobiol Aging 9:657\u2013666","journal-title":"Neurobiol Aging"},{"key":"105_CR155_105","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","volume":"17","author":"CE Wang","year":"2008","unstructured":"Wang CE, Tydlacka S, Orr AL, Yang SH, Graham RK, Hayden MR, Li S, Chan AW, Li XJ (2008) Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington\u2019s disease. Hum Mol Genet 17:2738\u20132751","journal-title":"Hum Mol Genet"},{"key":"105_CR156_105","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","volume":"22","author":"CL Wellington","year":"2002","unstructured":"Wellington CL, Ellerby LM, Gutekunst CA, Rogers D, Warby S, Graham RK, Loubser O, van Raamsdonk J, Singaraja R, Yang YZ, Gafni J, Bredesen D, Hersch SM, Leavitt BR, Roy S, Nicholson DW, Hayden MR (2002) Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington\u2019s disease. J Neurosci 22:7862\u20137872","journal-title":"J Neurosci"},{"key":"105_CR157_105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.febslet.2004.06.076","volume":"571","author":"CB Whitelaw","year":"2004","unstructured":"Whitelaw CB, Radcliffe PA, Ritchie WA, Carlisle A, Ellard FM, Pena RN, Rowe J, Clark AJ, King TJ, Mitrophanous KA (2004) Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector. FEBS Lett 571:233\u2013236","journal-title":"FEBS Lett"},{"key":"105_CR158_105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P, O'Kane CJ, Floto RA, Rubinsztein DC (2008) Novel targets for Huntington\u2019s disease in an mTOR-independent autophagy pathway. Nat Chem Biol 4:295\u2013305","journal-title":"Nat Chem Biol"},{"key":"105_CR159_105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","volume":"72","author":"B Woodman","year":"2007","unstructured":"Woodman B, Butler R, Landles C, Lupton MK, Tse J, Hockly E, Moffitt H, Sathasivam K, Bates GP (2007) The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res Bull 72:83\u201397","journal-title":"Brain Res Bull"},{"key":"105_CR160_105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature06975","volume":"453","author":"SH Yang","year":"2008","unstructured":"Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW (2008) Towards a transgenic model of Huntington\u2019s disease in a non-human primate. Nature 453:921\u2013924","journal-title":"Nature"},{"key":"105_CR161_105","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","volume":"109","author":"L Yang","year":"2009","unstructured":"Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Beal MF (2009) Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases. J Neurochem 109:1427\u20131439","journal-title":"J Neurochem"},{"issue":"14","key":"105_CR162_105","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.yexcr.2008.06.002","volume":"314","author":"JY Yu","year":"2008","unstructured":"Yu JY, Chung KH, Deo M, Thompson RC, Turner DL (2008) MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp Cell Res 314(14):2618\u201333","journal-title":"Exp Cell Res"},{"issue":"1","key":"105_CR163_105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2009.08.001","volume":"94","author":"D Zadori","year":"2009","unstructured":"Zadori D, Geisz A, Vamos E, Vecsei L, Klivenyi P (2009) Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington\u2019s disease. Pharmacol Biochem Behav 94(1):148\u201353","journal-title":"Pharmacol Biochem Behav"},{"key":"105_CR164_105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E (2003) Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35:76\u201383","journal-title":"Nat Genet"},{"key":"105_CR165_105","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","volume":"27","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Belyaev N, Conforti P, Ooi L, Tartari M, Papadimou E, MacDonald M, Fossale E, Zeitlin S, Buckley N, Cattaneo E (2007) Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington\u2019s disease. J Neurosci 27:6972\u20136983","journal-title":"J Neurosci"}],"container-title":["Current Topics in Behavioral Neurosciences","Molecular and Functional Models in Neuropsychiatry"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2010_105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T23:57:17Z","timestamp":1637107037000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2010_105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9783642197024","9783642197031"],"references-count":165,"URL":"https:\/\/doi.org\/10.1007\/7854_2010_105","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}